Most cited papers from Kancera (Sweden)

Kancera (Sweden)

What are the most cited papers from Kancera (Sweden)?

The most cited paper from Kancera (Sweden) is "Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination" (Nina Gustafsson et al., 2018), with 133 citations. Next come "Identification of novel quinazoline derivatives as potent antiplasmodial agents" (65) and "CD163+ macrophages monitor enhanced permeability at the blood–dorsal root ganglion barrier" (57).

Published TypeFieldAccess

Showing 30 of 30 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination Nina Gustafsson et al. · Nature Communications Open access	18 Sep 2018	133
2	Identification of novel quinazoline derivatives as potent antiplasmodial agents Anne Bouchut, Dante Rotili, Christine Pierrot et al. · European Journal of Medicinal Chemistry Open access	17 Oct 2018	65
3	CD163+ macrophages monitor enhanced permeability at the blood–dorsal root ganglion barrier Harald Lund, Matthew A. Hunt, Zerina Kurtović et al. · The Journal of Experimental Medicine Open access	28 Nov 2023	57
4	First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells Mohammad Hojjat‐Farsangi, Amir Hossein Daneshmanesh, Abdul Salam Khan et al. · Leukemia Open access	27 Mar 2018	54
5	A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib Amir Hossein Daneshmanesh, Mohammad Hojjat‐Farsangi, Amineh Ghaderi et al. · PLoS ONE Open access	Jun 2018	45
6	Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer Rosaria Benedetti et al. · Cancers Open access	16 Dec 2019	41
7	ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells Amineh Ghaderi, Amir Hossein Daneshmanesh, Ali Moshfegh et al. · Biomedicines Open access	23 Jun 2020	38
8	Fractalkine Signalling (CX3CL1/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease Shu Xian Loh, Yasemin Ekinci, Luke Spray et al. · Journal of Clinical Medicine Open access	21 Jul 2023	31
9	The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation Aikaterini Gatsiou et al. · Immunity Open access	25 Apr 2023	25
10	Fluorescence-Based Screening Assays for the NAD+-Dependent Histone Deacetylase smSirt2 from Schistosoma mansoni Matthias Schiedel, Martin Marek, Julien Lancelot et al. · SLAS DISCOVERY Open access	17 Oct 2014	24
11	Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung Walter Wang, Konstantin Shilo, Joseph M. Amann et al. · Cell Death and Disease Open access	4 Jun 2021	22
12	Schistosome Sirtuins as Drug Targets Julien Lancelot, Alejandro Cabezas‐Cruz, Stéphanie Caby et al. · Future Medicinal Chemistry	Apr 2015	22
13	A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells Amineh Ghaderi, Wen Zhong, Mohammad Ali Okhovat et al. · Pharmaceutics Open access	20 Oct 2022	19
14	Species-selective targeting of pathogens revealed by the atypical structure and active site of Trypanosoma cruzi histone deacetylase DAC2 Martin Marek et al. · Cell Reports Open access	Dec 2021	18
15	A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells Amineh Ghaderi, Mohammad Ali Okhovat, Jemina Lehto et al. · Pharmaceutics Open access	5 Apr 2023	15
16	PFKFB3 Inhibition Sensitizes DNA Crosslinking Chemotherapies by Suppressing Fanconi Anemia Repair Anna Huguet Ninou, Jemina Lehto, Dimitrios Chioureas et al. · Cancers Open access	18 Jul 2021	13
17	Targeting the Receptor Tyrosine Kinase ROR1 by Small Molecules Mohammad Hojjat‐Farsangi, Ali Moshfegh, Johan Schultz et al. · Handbook of experimental pharmacology Book chapter	2021	12
18	A ROR1 small molecule inhibitor (KAN0441571C) induced significant apoptosis of ibrutinib‐resistant ROR1+ CLL cells Amineh Ghaderi, Mohammad Ali Okhovat, Layung Sekar Sih Wikanthi et al. · eJHaem Open access	20 May 2021	12
19	Targeting CX3CR1 Suppresses the Fanconi Anemia DNA Repair Pathway and Synergizes with Platinum Jemina Lehto, Anna Huguet Ninou, Dimitrios Chioureas et al. · Cancers Open access	22 Mar 2021	8
20	Bugs improve nerve regeneration: fasting-induced, microbiome-derived metabolite enhances peripheral nerve regeneration Zerina Kurtović, Camilla I. Svensson, Emerson Krock · Signal Transduction and Targeted Therapy Open access	5 Oct 2022	7
21	5234KAND567, the first selective small molecule CX3CR1 antagonist in clinical development, mediates anti-inflammatory cardioprotective effects in rodent models of atherosclerosis and myocardial infarction Sally Abdelmoaty, Helen M. Arthur, Ioakim Spyridopoulos et al. · European Heart Journal	Oct 2019	7
22	First-in-Class ROR1 Small Molecule Inhibitor (KAN0439834) Downregulated Wnt-Canonical and Non-Canonical Signaling Pathways and Induced Apoptosis of CLL Cells Mohammad Hojjat‐Farsangi, Ali Moshfegh, Amir Hossein Daneshmanesh et al. · Blood	3 Dec 2015	6
23	A Small Molecule Antagonist of CX3CR1 (KAND567) Inhibited the Tumor Growth-Promoting Effect of Monocytes in Chronic Lymphocytic Leukemia (CLL) Wen Zhong, Parviz Kokhaei, Tom A. Mulder et al. · Cancers Open access	13 Nov 2024	5
24	A network of CD163 + macrophages monitors enhanced permeability at the blood-dorsal root ganglion barrier Harald Lund, Matthew A. Hunt, Zerina Kurtović et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	27 Mar 2023	5
25	circRNA landscape in dorsal root ganglia from mice with collagen antibody-induced arthritis Zerina Kurtović, Katalin Sándor, Freija ter Heegde et al. · Neurobiology of Pain Open access	Aug 2023	4
26	First generation of a small chemical molecule ROR1 RTK tyrosine kinase inhibitor Håkan Mellstedt, Mohammad Hojjat‐Farsangi, Amir Hossein Daneshmanesh et al. · Annals of Oncology Open access	Oct 2016	3
27	Phosphorylation of Receptor Tyrosine Kinase ROR1 At Tyrosine 641, 646 and Serine 652 residues Might Be of Importance for the Survival of CLL Leukemic Cells Mohammad Hojjat‐Farsangi, Amir Hossein Daneshmanesh, Martin Norin et al. · Blood	16 Nov 2012	2
28	Inhibition of fractalkine signalling in patients with acute myocardial infarction - First results from the FRACTAL trial Su Peng Loh, Yakup Ekinci, Karim Bennaceur et al. · European Heart Journal	Oct 2024	1
29	First-in-Class Oral Small Molecule Against the Tyrosine Kinase ROR1 (KAN0439834) Induced Significant Apoptosis of Chronic Lymphocytic Leukemia Cells Mohammad Hojjat‐Farsangi, Amir Hossein Daneshmanesh, Fariba Mozaffari et al. · Blood	7 Dec 2017	1
30	Fractalkine Inhibition in Acute Myocardial Infarction leads to reduced intramyocardial haemorrhage Su Peng Loh, Yakup Ekinci, Karim Bennaceur et al. · European Heart Journal	Oct 2024	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.